Short-chain fatty acids (SCFAs) serve as key signaling molecules linking gut microbiota and host health. Microbially produced SCFAs in the colon are generally acknowledged for their beneficial effects on cardiometabolic health, ...
Jan 24, 2025
0
0
Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher rates of remission compared ...
Jan 23, 2025
0
0
Gangrene, or a rapidly spreading foot abscess. Sound like diseases of the past? Well, sadly not.
Jan 21, 2025
0
0
People with type 2 diabetes had significantly fewer heart attacks, strokes, heart failures, and deaths from cardiovascular disease when their blood pressure was lower than the current standard goal, a UT Southwestern Medical ...
Jan 20, 2025
0
0
A significant portion of the Greenlandic Inuit population carries a genetic variant that increases their risk of type 2 diabetes tenfold. Now, researchers from the University of Copenhagen have discovered that the key to ...
Jan 20, 2025
0
13
A completely new way of treating type 1 diabetes is being tested at Uppsala University Hospital. Patients are being offered transplants of genetically modified insulin-producing cells and the initial results are promising. ...
Jan 17, 2025
0
0
Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, University of Virginia Center for Diabetes Technology researchers have found. That suggests doctors may be able to ...
Jan 15, 2025
0
2
Women who have gestational diabetes have increased risk of type 2 diabetes in the years after delivery. Those who go on to develop the chronic disease fall into three "clusters," each with a distinct molecular driver, according ...
Jan 15, 2025
0
0
Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially approved for managing type 2 diabetes. While there is currently limited data on its risks and benefits ...
Jan 15, 2025
0
22
Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, according to a study published online Dec. 18 in the International ...
Jan 14, 2025
0
0
